Nā huahana
-
ʻAkika Nukleika Plasmodium
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka qualitative in vitro o ka malaria parasite nucleic acid i loko o nā hāpana koko peripheral o nā maʻi i manaʻo ʻia he maʻi plasmodium.
-
ʻO ka waikawa nukleika Candida Albicans
Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana in vitro o ka waikawa nucleic Candida Albicans i loko o nā hāpana hoʻokuʻu vaginal a me nā hāpana sputum.
-
ʻO ka waikawa nukleika Candida Albicans
Ua manaʻo ʻia kēia pahu hana no ka ʻike qualitative in vitro o ka waikawa nucleic o Candida tropicalis i nā laʻana o ke ala genitourinary a i ʻole nā laʻana sputum lapaʻau.
-
ʻO ka mea hoʻohuihui maʻi influenza A/B
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative o nā antigens influenza A a me B i loko o nā laʻana swab oropharyngeal a me nā laʻana swab nasopharyngeal.
-
ʻO ka maʻi hanu o ka Hikina Waena Coronavirus Nucleic Acid
Hoʻohana ʻia ka pahu hana no ka ʻike qualitative o ka MERS coronavirus nucleic acid i loko o nā swabs nasopharyngeal me ka Middle East Respiratory Syndrome (MERS) coronavirus.
-
ʻO ka waikawa nukleika Mycoplasma Pneumoniae
Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana i ka waikawa nucleic Mycoplasma pneumoniae (MP) in vitro i loko o nā swabs ʻāʻī kanaka.
-
14 ʻAno o ka HPV Nucleic Acid Typing
No ka ʻohana Papillomaviridae ka Human Papillomavirus (HPV) o kahi maʻi DNA poepoe pālua liʻiliʻi, ʻaʻole i hoʻopuni ʻia, me ka lōʻihi o ka genome ma kahi o 8000 mau hui kumu (bp). Hoʻopilikia ka HPV i nā kānaka ma o ka pili pololei a ʻaʻole paha me nā mea i haumia a i ʻole ka lawe ʻana i ka moekolohe. ʻAʻole wale ka maʻi i kikoʻī i ka mea hoʻokipa, akā i kikoʻī pū kekahi, a hiki ke hoʻopilikia wale i ka ʻili kanaka a me nā pūnaewele epithelial mucosal, e hana ana i nā ʻano papillomas a i ʻole nā warts i loko o ka ʻili kanaka a me ka hōʻino nui ʻana i ka epithelium o ke ala hānau.
He kūpono kēia pahu hana no ka ʻike ʻana i ke ʻano qualitative in vitro o nā ʻano 14 o nā human papillomaviruses (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) nucleic acids i loko o nā laʻana mimi kanaka, nā laʻana swab cervical wahine, a me nā laʻana swab vaginal wahine. Hiki iā ia ke hāʻawi wale i nā mea kōkua no ka ʻike ʻana a me ka mālama ʻana i ka maʻi HPV.
-
ʻO ka waikawa nukleika o ka maʻi influenza B
Ua manaʻo ʻia kēia pahu hana no ka ʻike qualitative in vitro o ka nucleic acid o ka maʻi Influenza B i nā laʻana swab nasopharyngeal a me oropharyngeal.
-
ʻO ka waikawa nukleika o ka maʻi influenza A
Hoʻohana ʻia ka pahu hana no ka ʻike qualitative o ka nucleic acid o ka maʻi Influenza A i loko o nā swabs pharyngeal kanaka in vitro.
-
19 ʻAno o ka Pathogen Hanu Nucleic Acid
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka SARS-CoV-2, ka maʻi influenza A, ka maʻi influenza B, adenovirus, mycoplasma pneumoniae, chlamydia pneumoniae, ka maʻi respiratory syncytial a me ka maʻi parainfluenza (Ⅰ, II, III, IV) i loko o nā swabs puʻu a me nā laʻana sputum, human metapneumovirus, haemophilus influenzae, streptococcus pneumoniae, klebsiella pneumoniae, staphylococcus aureus, pseudomonas aeruginosa, legionella pneumophila a me acinetobacter baumannii.
-
ʻO ka waikawa nukleika Neisseria Gonorrhoeae
Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana i ka waikawa nucleic Neisseria Gonorrhoeae (NG) in vitro i loko o ka mimi kāne, ka swab urethral kāne, nā hāpana swab cervical wahine.
-
4 ʻAno o nā maʻi hanu Nucleic Acid
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka SARS-CoV-2, ka maʻi influenza A, ka maʻi influenza B a me nā waikawa nucleic virus syncytial respiratory i loko o nā hāpana swab oropharyngeal kanaka.
